Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELUXADOLINE vs EMPAGLIFLOZIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELUXADOLINE vs EMPAGLIFLOZIN: Safety Overview

Metric ELUXADOLINE EMPAGLIFLOZIN
Total FAERS Reports 2,353 37,059
Deaths Reported 37 1,624
Death Rate 1.6% 4.4%
Hospitalizations 413 12,216
Average Patient Age 57.4 yrs 64.3 yrs
% Female Patients 77.7% 46.0%
FDA Approval Date Mar 14, 2025 Aug 1, 2014
Manufacturer Allergan, Inc. Cardinal Health 107, LLC
Route ORAL ORAL
Marketing Status Prescription Prescription